Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Mailman

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Brain Research|September 12, 2006
Low affinity binding of the classical D1 antagonist SCH23390 in rodent brain: potential interaction with A2A and D2-like receptorsSarah K Leonard, Penelope Ferry-Leeper, Richard B Mailman
Molecular Pharmacology|June 30, 2005
Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonistsJessica P Ryman-Rasmussen, David E Nichols, Richard B Mailman
The Journal of Pharmacology and Experimental Therapeutics|June 6, 2022
A Dopamine D<sub>1</sub> Agonist Versus Methylphenidate in Modulating Prefrontal Cortical Working MemoryYang Yang, Mechelle M Lewis, Lan Kong, et al.
The Neurologist (Hyderabad, India)|August 29, 2018
Distinct neuroimaging features define Parkinson's disease and welding-related neurotoxicityEun-Young Lee, Mechelle M Lewis, Richard B Mailman, et al.
Nature Communications|November 27, 2023
Resting-state global brain activity affects early β-amyloid accumulation in default mode networkFeng Han, Xufu Liu, Richard B Mailman, et al.
Frontiers in Neuroscience|July 5, 2022
Dose-Dependent Regulation on Prefrontal Neuronal Working Memory by Dopamine D<sub>1</sub> Agonists: Evidence of Receptor Functional Selectivity-Related MechanismsYang Yang, Susan D Kocher, Mechelle M Lewis, et al.
Advances in Medical Education and Practice|September 19, 2022
Clinician-Scientist Faculty Mentoring Program (FAME) - A New Inclusive Training Model at Penn State Increases Scholarly Productivity and Extramural Grant FundingSinisa Dovat, Chandrika Gowda, Richard B Mailman, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 20, 2019
Cancer and the Dopamine D<sub>2</sub> Receptor: A Pharmacological PerspectiveJillian S Weissenrieder, Jeffrey D Neighbors, Richard B Mailman, et al.
Psychopharmacology|August 14, 2023
Characterization of behavioral changes in T-maze alternation from dopamine D<sub>1</sub> agonists with different receptor coupling mechanismsJack X Cimino, Mi Zhou, James Waxmonsky, et al.
Research Square|February 6, 2026
Concomitant activation of D1 dopamine and α2A adrenergic receptors for symptoms of ADHD: comparison with methylphenidateLuke Bransom, Ava P Bassett, Mi Zhou, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Brain Research|September 12, 2006
Low affinity binding of the classical D1 antagonist SCH23390 in rodent brain: potential interaction with A2A and D2-like receptorsSarah K Leonard, Penelope Ferry-Leeper, Richard B Mailman
Molecular Pharmacology|June 30, 2005
Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonistsJessica P Ryman-Rasmussen, David E Nichols, Richard B Mailman
The Journal of Pharmacology and Experimental Therapeutics|June 6, 2022
A Dopamine D<sub>1</sub> Agonist Versus Methylphenidate in Modulating Prefrontal Cortical Working MemoryYang Yang, Mechelle M Lewis, Lan Kong, et al.
The Neurologist (Hyderabad, India)|August 29, 2018
Distinct neuroimaging features define Parkinson's disease and welding-related neurotoxicityEun-Young Lee, Mechelle M Lewis, Richard B Mailman, et al.
Nature Communications|November 27, 2023
Resting-state global brain activity affects early β-amyloid accumulation in default mode networkFeng Han, Xufu Liu, Richard B Mailman, et al.
Frontiers in Neuroscience|July 5, 2022
Dose-Dependent Regulation on Prefrontal Neuronal Working Memory by Dopamine D<sub>1</sub> Agonists: Evidence of Receptor Functional Selectivity-Related MechanismsYang Yang, Susan D Kocher, Mechelle M Lewis, et al.
Advances in Medical Education and Practice|September 19, 2022
Clinician-Scientist Faculty Mentoring Program (FAME) - A New Inclusive Training Model at Penn State Increases Scholarly Productivity and Extramural Grant FundingSinisa Dovat, Chandrika Gowda, Richard B Mailman, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 20, 2019
Cancer and the Dopamine D<sub>2</sub> Receptor: A Pharmacological PerspectiveJillian S Weissenrieder, Jeffrey D Neighbors, Richard B Mailman, et al.
Psychopharmacology|August 14, 2023
Characterization of behavioral changes in T-maze alternation from dopamine D<sub>1</sub> agonists with different receptor coupling mechanismsJack X Cimino, Mi Zhou, James Waxmonsky, et al.
Research Square|February 6, 2026
Concomitant activation of D1 dopamine and α2A adrenergic receptors for symptoms of ADHD: comparison with methylphenidateLuke Bransom, Ava P Bassett, Mi Zhou, et al.
Pageof 10